Research News and Research

RSS

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria. The study will evaluate the safety, tolerability and pharmacokinetics of AN3365 in healthy volunteers.

17 Nov 2009

China Sky One Medical reports financial results for third-quarter 2009

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced record financial results for the third quarter of 2009.

17 Nov 2009

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology(R), today announced that the company has obtained clearance by the U.S. Food and Drug Administration (FDA) to market its ASAP Antibacterial Silver Wound Dressing Gel as a prescription 510(k) medical device throughout the United States. Clifton Mining Company is a major shareholder in American Biotech Labs.

17 Nov 2009

Second-quarter fiscal 2010 results announced by China-Biotics

China-Biotics, Inc., a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financial results for the second quarter of its 2010 fiscal year, ended September 30, 2009.

17 Nov 2009

Bayer's NEXAVAR approved in over 70 countries for the treatment of liver cancer

Bayer Inc. announced today that its international trial known as SHARP (Sorafenib HCC Assessment Randomized Protocol), led by Study Manager and Bayer Canada employee Tom Giannaris, has been selected as the winner in the 'Best International Trial' category for the Global Clinical Practice Journal Awards.

17 Nov 2009

First Edition: November 17, 2009

Based on today's headlines, all eyes continue to be focused on the Senate -- where Democratic leaders are still waiting for the revised Congressional Budget Office analysis of their health bill and plotting about when to hold the first procedural vote on the measure.

17 Nov 2009

Scientists solve 50-year-old thalidomide puzzle

Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published in Bio-Essays, outlines the challenges surrounding thalidomide research and claims that confirmation of a 'common mechanism' could lead to new treatments for Leprosy, Crohn's Disease, AIDS and some forms of cancer..

17 Nov 2009

Illinois and Michigan teens honored at 2009 Siemens Competition

Research projects in the areas of biology and mathematics scored top marks this evening, as Marissa Suchyta of South Barrington, Illinois and the team of Randy Jia of Rochester Hills, Michigan and David Lu of Bloomfield Hills, Michigan received the highest honors at the Region Three Finals of the 2009 Siemens Competition in Math, Science & Technology, the nation's premier high school science competition.

17 Nov 2009

MEMS: Sensors made for automobiles are being used for healthcare devices

MEMS industry execs attending the annual MEMS Executive Congress last week were rapt by presentations and panel discussions by leading innovators in automotive, bio/medical, consumer electronics, mobile communications and energy. Buoyed by optimistic forecasts for microelectromechanical systems (MEMS) devices such as accelerometers and multi-axis gyros—increasingly used in mobile handsets and video games—they engaged with keynote speaker Dr. Mauro Ferrari, professor and director of The Division of NanoMedicine and Deputy Chairman of The University of Texas Department of Biomedical Engineering, whose proteomic NanoChips and multi-stage drug-delivery systems may one day ‘cure cancer.’

17 Nov 2009

Researchers study different plant substances to "awaken" the latent HIV-1 virus

Researchers from the University of Cadiz and the University of Cordoba study different plant substances to "awaken" the latent HIV-1 virus, immune to the current therapy, and to obtain more effective treatments in the future.

17 Nov 2009

Most employers concerned over the ramifications of potential healthcare reform legislation: IDC study

IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.

17 Nov 2009

New rapid screening methods for BPA using Waters ACQUITY UPLC published in ASTM International

Waters Corporation (NYSE: WAT) today hosted Dr. Lawrence Zintek, National Organic Methods Development Expert, United States Environmental Protection Agency Region 5 Central Regional Laboratory in Chicago, and author of two new rapid screening methods for Alkylphenols and Bisphenol A (BPA) using Waters® ACQUITY UPLC®/Quattro Premier(TM) XE (UPLC/MS/MS) recently published in American Society for Testing and Materials (ASTM) International. Dr. Zintek was the keynote speaker at a Waters' breakfast seminar held in conjunction with the Water Quality Technology Conference sponsored by the American Water Works Association in Seattle.

17 Nov 2009

Consortium to define new modalities for treating hypertension and associated vascular complications

Top Institute Pharma has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension (high blood pressure) and associated vascular complications such as heart and kidney failure, myocardial infarction and stroke.

17 Nov 2009

Performance of male and female leaders is largely linked to gender typing environment

Although women have made strides in the business world, they still occupy less than two percent of CEO leadership positions in the Fortune 500. Not surprisingly therefore leaders still tend to be thought of as men and most industries are considered to be male-typed at management levels.

17 Nov 2009

Advanced BioMedical Technologies commences animal tests with novel patented PA bio-absorbable material

Advanced BioMedical Technologies Inc. announced that the Company's subsidiary, Shenzhen Changhua Biomedical Engineering Co., Ltd., has signed a cooperative agreement with The First Affiliated Hospital of Guangdong Pharmaceutical University ("GDPU Hospital") in Guangzhou. Under this cooperative agreement, both parties will join efforts in conducting research and animal tests on Cranio-Maxillofacial Fracture Treatment and Craniofacial Reconstruction utilizing ABT-CHANGHUA's novel patented PA (Polyamide) bio-absorbable material.

17 Nov 2009

Statistical analysis for measuring the quality of life related to health

The Biostatistics research team at the Department of Applied Mathematics, Statistics and Operational Research of the University of the Basque Country is working on applied statistics based on health sciences and experimental sciences under the leadership of Ms Inma Arostegui.

17 Nov 2009

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.

17 Nov 2009

CMS policy changes to drive the sleep management devices market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, policy changes made by the Center for Medicare and Medicaid Services (CMS) will cause a surge in obstructive sleep apnea (OSA) diagnostic testing and treatment. MRG's new US Market Opportunities for Respiratory and Sleep Management Devices 2010 report finds that increasing reimbursement opportunities for OSA diagnosis and treatment will drive the OSA market to $1.5 billion by 2014.

17 Nov 2009

Recent developments at Burnham Institute for Medical Research

New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria. Andrei Osterman and collaborators have used comparisons of bacterial genomes to identify new targets for antibiotics and produced first-generation chemical inhibitors of a class of bacterial enzymes, called NadDs (nicotinate mononucleotide adenylyltransferases).

17 Nov 2009

New insights into cells' reaction to DNA damage

Cancer researchers of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have gained new insights into how cells react to DNA damage. Dr. Michael Stilmann, Dr. Michael Hinz and Professor Claus Scheidereit have shown that the protein PARP-1, which detects DNA damage within seconds, activates the transcription factor NF-kappaB, a well-known regulator of gene expression.

17 Nov 2009

Research News and Research

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

China Sky One Medical reports financial results for third-quarter 2009

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

Second-quarter fiscal 2010 results announced by China-Biotics

Bayer's NEXAVAR approved in over 70 countries for the treatment of liver cancer

First Edition: November 17, 2009

Scientists solve 50-year-old thalidomide puzzle

Illinois and Michigan teens honored at 2009 Siemens Competition

MEMS: Sensors made for automobiles are being used for healthcare devices

Researchers study different plant substances to "awaken" the latent HIV-1 virus

Most employers concerned over the ramifications of potential healthcare reform legislation: IDC study

New rapid screening methods for BPA using Waters ACQUITY UPLC published in ASTM International

Consortium to define new modalities for treating hypertension and associated vascular complications

Performance of male and female leaders is largely linked to gender typing environment

Advanced BioMedical Technologies commences animal tests with novel patented PA bio-absorbable material

Statistical analysis for measuring the quality of life related to health

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

CMS policy changes to drive the sleep management devices market

Recent developments at Burnham Institute for Medical Research

New insights into cells' reaction to DNA damage

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring